Andrew James King, Chief Scientific Officer at CHINOOK THERAPEUTICS, INC. (KDNY), sold 7,114 shares at $19.69 ($140K) on 2022-10-06, disclosed to the SEC on 2022-10-11.
Open-market sale of $140k KDNY by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.69 | 3,557 | $70K | 50.0% |
| 2 | $19.69 | 3,557 | $70K | 50.0% |
| Total | $19.69 avg | 7,114 | $140K | 100% |
| Filing → |
| KDNY | SELL | 2023-02-15 | $57K | — | Filing → |
| KDNY | SELL | 2023-02-02 | $160K | — | Filing → |
| KDNY | SELL | 2023-01-04 | $258K | — | Filing → |